PAUL SELID, M.D.
Cornea and External Diseases Specialist Physician in BISMARCK, North Dakota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: PAUL SELID, M.D. reported a CMS MIPS final score of 75.2866 out of 100, below the 83.1 national average, and filed 2,449 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
PAUL SELID, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
PAUL SELID, M.D. at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in North Dakota
How Cornea and External Diseases Specialist Physician compares to other specialties among North Dakota providers
Cornea and External Diseases Specialist Physician share within North Dakota
Cornea and External Diseases Specialist Physician is one of the more visible NUCC categories in North Dakota
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
PAUL SELID, M.D.'s 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average
- MIPS Final Score
- 75.2866/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cornea and External Diseases Specialist Physician) — 75.2866/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Cornea and External Diseases Specialist Physician US NPIs
75.2866/100 MIPS final score — 7.8 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cornea and External Diseases Specialist Physician. Quality dim: 100. Cost dim: 17.622.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
PAUL SELID, M.D. is a Cornea and External Diseases Specialist Physician provider practicing in BISMARCK, North Dakota, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1699186155. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
PAUL SELID, M.D. appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider holding M.D. credentials at 3119 N 14TH ST, BISMARCK, ND, 58503, with a listed phone of (701) 222-3937. NPI 1699186155 was issued on 05/17/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SELID most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,449 prescription claims written by this provider, covering 598 Medicare beneficiaries and totaling roughly $620K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.2866/100 for the 2023 performance year (Quality 100, Cost 17.622), compared with the national average of 83.1.
Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1699186155 |
|---|---|
| Specialty | Cornea and External Diseases Specialist Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/17/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm PAUL SELID, M.D.'s current license status, disciplinary history, and board certifications with the North Dakota Board of Medicine in North Dakota before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where PAUL SELID, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PAUL SELID, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$283
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
40% brand-name claims vs 60% generic, on 2,449 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,712
- Total Day Supply
- 98,612
- Brand vs Generic
- 40% brand / 60% generic
- Brand Drug Cost
- $575K
- Generic Drug Cost
- $45K
- Antibiotic Claims
- 36
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 1.10
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 43, 65-74: 270, 75-84: 202, 85+: 83
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 595 |
| Latanoprost | 454 |
| Ofloxacin | 244 |
| Valacyclovir Valacyclovir Hcl | 231 |
| Moxifloxacin Moxifloxacin Hcl | 178 |
| Fluorometholone | 106 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 92 |
| Timolol Maleate | 86 |
| Ketorolac Tromethamine | 66 |
| Restasis Cyclosporine | 61 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cornea and External Diseases Specialist Physician Overview
How PAUL SELID, M.D. fits within the Cornea and External Diseases Specialist Physician landscape nationally.
PAUL SELID, M.D.'s 2,449 claims are above the specialty average of 1,232.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore North Dakota
Frequently Asked Questions
What is PAUL SELID, M.D.'s specialty? ▼
How much does PAUL SELID, M.D. prescribe under Medicare Part D? ▼
What is PAUL SELID, M.D.'s Medicare quality score? ▼
Where is PAUL SELID, M.D. located? ▼
What is PAUL SELID, M.D.'s NPI number? ▼
Does PAUL SELID, M.D. prescribe more brand-name or generic drugs? ▼
How many Cornea and External Diseases Specialist Physician providers are there in the US? ▼
What drugs does PAUL SELID, M.D. prescribe most often? ▼
Does PAUL SELID, M.D. accept Medicare? ▼
How can I verify PAUL SELID, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology